Management of HIV infection for the childbearing age woman

Clinical Obstetrics and Gynecology

Volumn 39, Issue 2, 1996, Pages 344-360

  Bardeguez, Arlene D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DAPSONE; ERYTHROPOIETIN; FOSCARNET; GANCICLOVIR; ISONIAZID; PENICILLIN G; PENTAMIDINE; PYRIDOXINE; RIFABUTIN; ZIDOVUDINE;

AIDS RELATED COMPLEX; ANEMIA; BACTERIAL PNEUMONIA; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; REVIEW; SYPHILIS; THROMBOCYTOPENIA; TOXOPLASMOSIS; TREATMENT PLANNING; TUBERCULOSIS; UTERINE CERVIX DYSPLASIA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; OBSTETRIC LABOR COMPLICATIONS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0029884034     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199606000-00009     Document Type: Review

References (106)

1. World Health Organization. The current global situation of the HIV/AIDS pandemic. Geneva, Switzerland: World Health Organization, 1995.
2. First 500,000 AIDS Cases-United States, 1995. MMWR. 1995;44:849-853.
3. Update: Acquired Immunodeficiency Syndrome-United States, 1992. MMWR. 1993;42:547-557.
4. Selik RM, Chu SY, Buehler JW. HIV Infection as leading cause of death among young adults in US cities and states. JAMA. 1993;269:2991-2994.
5. Wasser SC, Gwinn M, Fleming P, Urban-Non urban distribution of HIV infection in childbearing women in the United States. J AIDS. 1993;6:1035-1042.
6. Minkoff HL, deRegt RH, Landesman S, et al. Pneumocystis carinii pneumonia associated with acquired immunodeficiency syndrome in pregnancy: a report of three maternal deaths. Obstet Gynecol. 1986;67: 284-287.
7. Bastian L, Bennett CL, Adams J, Waskin H, et al. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,000 cases in New York City in 1987. J AIDS. 1993;6:617-623.
8. Update: acquired immunodeficiency syndrome-United States, 1992. MMWR. 1993;42:547-557.
9. HIV/AIDS Surveillance Report. Mid-year Edition. U.S. Department of Health and Human Services. Public Health Service. Atlanta: Centers for Disease Control and Prevention, 1994.
10. Minkoff H, Mofenson LM. The role of obstetric interventions in the prevention of pediatric human immunodeficiency virus. Am J Obstet Gynecol. 1994;171:1167-1175.
11. Recommendations of the U.S. Public Health Service Task Force on the use of Zidovudine to reduce perinatal transmission of the human immunodeficiency virus. MMWR. 1994;43:1-20.
12. U.S. Public Health Service Recommendations for Human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR. 1995;44:1-15.
13. Lindsay MK. A protocol for routine voluntary antepartum human immunodeficiency virus antibody screening. Am J Obstet Gynecol. 1993;168:476-479.
14. Hecht FM, Soloway B, eds. HIV Infection: A Primary Care Approach. Second Edition. Boston: The Publishing Division of the Massachusetts Medical Society, 1994.
15. Clinical Practice Guideline. Evaluation and Management of early HIV infection. U.S. Department of Health and Human Services. Public Health Service Agency for Health care policy and Research. AHCPR Publication No. 94-0572, 1994.
16. Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults. MMWR. 1992;41:17.
17. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons with human immunodeficiency virus: a summary. MMWR. 1995;44:1-34.
18. European Collaborative Study. Risk factors for mother to child transmission of HIV-1. Lancet. 1992;339:1007-1012.
19. De Rossi A, Pasti M, Mammano F, Ometto L, Giaquinto C, Chieco-Bianchi L. Perinatal infection by human immunodeficiency type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome. J Med Virol. 1991;35:283-289.
20. Volberding PA, Lagakos SW, Kock MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection, a controlled trial in persons with fewer than 500 CD4 positive cells per cubic millimeters. N Engl J Med. 1990;332:941-949.
21. Kahn JO, Lagakos, Richman DD, et al A controlled trial comparing continued zidovudine with didanosine in HIV infection. N Engl J Med. 1992;327:581-587.
22. Bennett JC, For the Board on Health Sciences of the Institute of Medicine. Inclusion of women in clinical trials - policies for population subgroups. N Engl J Med. 1993;329:288-292.
23. Merkatz RB, Temple R, Sobel S, Feiden K, Kessler DA, and the Working Group of Women in Clinical Trials. Women in clinical trials of new drugs: a change in Food and Drug Administration policy. N Engl J Med. 1993;329;292-296.
24. Toltzis P. Rationales for treating the human immunodeficiency virus-infected women during pregnancy: current controversies in Perinatal Care. Clinics in Perinatology. 1993;20:47-60.
25. Davis SF, Byers RH, Lindegren ML, Caldwell B, Karon JM, Gwinn M Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995;247:952-955.
26. O'Sullivan MJ, Boyer PJJ, Scott GB, et al. The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I AIDS Clinical Trials Group Study (protocol 082). Am J Obstet Gynecol. 1993;168:1510-1516.
27. Connor EM, Sperling RS, Gelber R, et al Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
28. HIV Information Network. FAX Newsletter. The University of Alabama at Birmingham, 1995.
29. Harris MW, Chapin RE, Lockhart AC, Jokinen MP. Assessment of short-term reproductive and developmental toxicity screen. Fundamental and Applied Toxicology. 1992;19:186-196.
30. Harb GE, Alldredge BK, Coleman R, Jacobson MA. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with human immunodeficiency virus disease. J AIDS. 1993;6:919-926.
31. Olano JP, Borucki MJ, Wen JW, Haque AK Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis. 1995;21:973-976.
32. Doweiko JP. Hematologic aspects of HIV infection. AIDS. 1993;7:753-757.
33. Nahlen B, Chu S, Hanson D, Farizo K, and the Adult Adolescent Spectrum of HIV Disease Study Group. Anemia among HIV-infected adults in the US. Abstract WS-B22-20. IX International Congress on AIDS/STDs, Berlin, 1993.
34. Alger L, Parley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol. 1993;82:787-796.
35. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989;261: 3104-3107.
36. Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. Serum erythropoietin titers in patients with human immunodeficiency virus infection and anemia. J AIDS. 1991;4:593-597.
37. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med. 1990;322:1488-1493.
38. Yankowitz J, Piraino B, Laifer SA, Frassetto L, Gavin L, Kitzmiller JL, Crombleholme W. Erythropoietin in pregnancies complicated by severe anemia of renal failure. Obstet Gynecol. 1992;80:485-488.
39. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Research and Human Retrovirus. 1990;6:261-269.
40. Landonio G, Nosari A, Spinelli F, Vigorelli R, Caggese L, Schlacht I. HIV-related thrombocytopenia: four different clinical subsets. Haematologica. 1992;77:398-401.
41. Glantz JC, Roberts DJ. Pregnancy complicated by thrombocytopenia secondary to human immunodeficiency virus infection. Obstet Gynecol. 1994;83:825-827.
42. Mandelbrot L, Schlienger I, Bongain A, et al. Thrombocytopenia in pregnant women infected with human immunodeficiency virus: maternal and neonatal outcome. Am J Obstet Gynecol. 1994;171:252-257.
43. Glatt AE, Anand A. Thrombocytopenia in patients with Human immunodeficiency virus: treatment update. Clin Infect Dis. 1995;21:415-423.
44. Gringeri A, Cattaneo M, Sangostino E, Mannucci PM. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol. 1992;80:337-340.
45. Minkoff H.L, Henderson C, Mendez H, et al. Pregnancy outcomes among mothers infected with the human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol. 1990;163: 1598-1604.
46. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR. 1989;38.
47. Musher D. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis. 1991;163: 1201-1206.
48. Bardeguez A, Grandchamp J, Apuzzio J, Denny T, Wesley Y. Diagnosis of neurosyphilis in HIV-1 positive pregnant women: is CSF evaluation necessary? Annual Meeting of the Infectious Diseases Society for Obstetrics and Gynecology. Monterey, California, August 1994.
49. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med. 1995;333:845-851.
50. Update on adult immunization: recommendations of the immunization practices advisory committee. MMWR. 1991;40: 42-44.
51. Tuberculosis in Minorities-United States. MMWR. 1987;36:77-80.
52. Margono F, Mroueh J, Garely A, White D, Duerr A, Minkoff HL. Resurgence of active tuberculosis among pregnant women. Obstet Gynecol. 1994;83:911-914.
53. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-550.
54. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994;330:1710-1716.
55. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-1709.
56. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons: a prospective cohort study. JAMA. 1995;274:143-148.
57. Selwyn PA, Sckell BM, Alcabes P, et al. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268:504-509.
58. Dloch AB, Coruphen JM, Onorato IM, Bansbury KG, Kelly JD, Driver CR, Sneider DE. Nationwide survey of drug resistance to tuberculosis in the United States. JAMA. 1994;271:665-671.
59. Treatment of tuberculosis and tuberculous infection in adults and children. Am J Respir Crit Care Med. 1994;149:1359-1374.
60. Severe Isoniazid-associated hepatitis - New York, 1991-1993 MMWR. 1993; 42;545-554.
61. Chaisson RE, Schecter GF, Theuer CP, et al. Tuberculosis in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis. 1987;136:570-574.
62. Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
63. Cantwell MF, Shehab ZM, Costello AM, et al. Brief report: congenital tuberculosis. N Engl J Med. 1994;330:1051-1054.
64. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis. 1993;168:61-67.
65. Minkoff HL, Willoughby A, Mendez H, et al. Serious infections during pregnancy among women with advanced human immunodeficiency virus infection. Am J Obstet Gynecol. 1990;162:30-34.
66. Sperling RS, Stratton P, and Members of the Obstetric-Gynecologic Working Group of the AIDS Clinical Trials Group & the NIAID. Treatment options for human immunodeficiency virus-infected pregnant women. Obstet Gynecol. 1992;79:443-448.
67. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR. 1992;41: 1-12.
68. Nguyen M, Weiss PJ, Wallace MR. Two-day oral desensitization to trimethropinsulfamethoxazole in HIV-infected patients. AIDS. 1995;9:573-575.
69. Drew WL. Cytomegalvirus infection in patients with AIDS. Clin Infect Dis. 1992: 14:608-615.
70. de Smet, Nussenbatt RB. Ocular manifestations of AIDS. JAMA. 1991;266:3019-2230.
71. Feinberg J, Leport C, Reiss P. Update on opportunistic infections. AIDS. 1991: 5(Suppl 2):S195-S202.
72. Perinatal viral and parasitic infections. ACOG Technical Bulletin. 1993;177:1-7.
73. Ganciclovir. The Medical Letter on Drug and Therapeutics. 1989;31:79-80.
74. Foscarnet. The Medical Letter on Drug and Therapeutics. 1992;34:3-4.
75. Fowler KB, Stagno S, Pass RF. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663-676.
76. Chan ISF, Neaton JD, Saravolatz, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons. AIDS. 1995;9:1145-1151.
77. Decker CF, Masur H. Current status of prophylaxis for opportunistic infections in HIV-infected patients. AIDS. 1994;8:11-20.
78. Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avium complex bacteremia an its treatment on survival of AIDS patients - a prospective study. J Infect Dis. 1994;170:578-584.
79. Immunizations During Pregnancy. ACOG Technical Bulletin. 1991;160:1-10.
80. Recommendations of the advisory committee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR. 1993;2:1-18.
81. Apuzzio J. Immunizations during pregnancy. Case Studies in Obstetrics and Gynecology. Greenwich, CT: Clinical Communications, in press.
82. Tenerman M, Ephantus NC, Jackoniah N, Plummer FA, Coppens M, Piot P. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol. 1994;83:495-501.
83. Marquis JR, Bardeguez AD. Imaging of HIV-infection in the perinatal and postnatal period. Clinics in Perinatology. (In Press).
84. Gloeb DJ, O'Sullivan MJ, Efantis J. The effect of human immunodeficiency virus on pregnancy. Am J Obstet Gynecol. 1988;159:756-761.
85. Burns DN, Landesman S, Muenz LR, Nugent RP, Goedert JJ, Minkoff LR, Walsh JH, et al. Cigarette smoking, premature rupture of the membranes, and vertical transmission of HIV among women with low CD4 lymphocyte cell levels. J AIDS. 1994;68:4196-4203.
86. Minkoff H, Burns DN, Landesman S, et al The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol. 1995;173:585-589.
87. Selwyn PA, Shoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA. 1989;261:1289-1294.
88. Cullen MT, Sanchez-Ramos L, Delke I. Prenatal diagnosis of HIV-infection: the use of cordocentesis, polymerase chain reaction, and p24 antigen assay (abstract). Am J Obstet Gynecol. 1992;168:386.
89. Wada L, King JC. Trace element nutrition during pregnancy. Clin Obstet Gynecol. 1994;37:574-586.
90. Semba RD, Caiaffa WT, Graham NMH, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis. 1995;171: 1196-1202.
91. Semba RD, Miotti PG, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover R. Maternal vitamin A deficiency and mother to child transmission of HIV-1. Lancet. 1994;343:1593-1597.
92. Rothman KJ, Moore LL, Singer MR, Nguyen UDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333:1369-1373.
93. Marte C, Kelly P, Cohen M, et al. Papanicolaou smear abnormalities in ambulatory care sites for women infected with the human immunodeficiency virus. Am J Obstet Gynecol. 1992;166:1232-1237.
94. Bardeguez A. Editorial Comments to Pap Smear Recommendations from Evaluation and Management of early HIV infection. Clinical Practice Guidelines from the U.S. Department of Health and Human Services. The AIDS Reader. 1995;5:49-51, 72.
95. Maiman M, Frucher RG, Serur E, Levine PA, Arrastia CD, Sedlis A. Recurrent cervical dysplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1993;82:170-174.
96. Maiman M, Frucher RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol. 1990;38:377-382.
97. Viscarello RR, Copperman AB, DeGennaro NJ. Is the risk of perinatal transmission of human immunodeficiency virus increased by the intrapartum use of spiral electrodes or fetal scalp pH sampling? Am J Obstet Gynecol. 1994;170:740-743.
98. Villari P, Spino C, Chalmers TC, Lau J, Sacks HS. Caesarean section to reduce perinatal transmission of human immunodeficiency virus. A metaanalysis. The On-line Journal of Current Clinical Trials. 1993;74:930.
99. Sempri AE, Castagna C, Ravizza M, et al. The incidence of complications after cesarean section in 156 HIV-positive women. AIDS. 1995;9:913-917.
100. Van Voorhis BJ, Anderson DJ, Hill JA. The effect of RU 486 on immune function and steroid induced immunosuppression in vitro. J Clin Endocrinol Metab. 1989;69: 1195-1199.
101. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS. 1993;4: 165-170.
102. Plourde PJ, Ronald AR, Plummer FA. Human immunodeficiency virus transmission and oral contraceptives. J Infect Dis. 1993;167:1257-1258.
103. Have J, Minkoff H, Duerr A. Contraceptives and HIV. AIDS. 1994;3:871.
104. Ruff AJ, Halsey NA, Coberly J Breast feeding and maternal-infant transmission of human immunodeficiency virus type 1. J Pediatr. 1992;121:325-329.
105. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive mothers in Zaire. N Engl J Med. 1989;320:1637.
106. Nicoll A, Newell M, Praag EV, Van de Perre P, Peckham C. Infant feeding policy and practice in the presence of HIV-1 infection. AIDS. 1995;9:107-119.